about
The CD44+/CD24- phenotype is enriched in basal-like breast tumorsActivation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2aApparent exchange rate for breast cancer characterizationCD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markersRecurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.Molecular and genetic diversity in the metastatic process of melanomaPoor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencingSerial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic diseaseTopHat-Recondition: a post-processor for TopHat unmapped reads.Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells.Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somaticThe state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsiesEfficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant.Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA.Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinomaWhole-genome sequencing of triple-negative breast cancers in a population-based clinical studyPrediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based CohortAgreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancerCross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical seriesPre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrenceDetection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatmentTumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening TrialSubclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis
P50
Q21092906-C1D7BED1-3C06-4490-BC19-5F89F977BFD9Q24613036-7FB16B6A-26D1-4BB2-B9A1-647A44821A33Q31050692-F0706446-0F20-4B9A-86C5-8FFA8E00603FQ34034939-6B3B324B-0055-4B74-B8E1-3C5B2BDC6CA5Q34477787-22127FC5-55B3-48CD-92FF-457A339A936BQ35124700-1CEC6EC9-3C18-4AE8-809F-41AD9EB49B3DQ35145922-0AC12A95-65F1-44BC-8E2C-35CFF9EF4BECQ35177775-35BC5D7E-F902-46C0-A0A7-C1C33A299C59Q35757521-0BD64A96-E104-4698-A510-54E13D6EC590Q35869326-714B3A16-B1C8-4F63-89E6-14D83B69FBB1Q35936763-763EA38A-5D20-4DDC-868E-1B890AEFC833Q36000803-D6746C11-58D9-402C-81AC-927FA1062F2BQ36008145-6546F6B5-36DF-4FA0-9792-5C4D87D2E8D6Q36082731-96F45EF9-36D1-423E-94D5-3F9F0307DC19Q36677712-996B036B-165B-49DE-B21D-D69D0AAC7E58Q37123931-F3305C80-BAA8-429F-859F-9DA2B2DC1B1BQ37407810-20FC9494-230B-443B-A3E7-C3DB23966127Q37710168-F27AE692-DF0A-407D-8B31-108652AF64CCQ38925098-3212468E-25D9-4745-83BF-C0F5D7F827BCQ39115537-37C2A6A1-1063-4DF2-81B5-9DB786E90300Q39319266-8FDACB56-9B00-4928-8BB8-1C20B4553090Q39329911-5CE0329B-67B5-449A-93E8-E0D4CB396624Q43708523-750B870F-7508-4AC0-BC29-BC1477DB40B3Q48102903-83F18BB7-6FAE-4100-B6AB-AE2C131777B5Q48229387-040B3293-B8FE-4FA7-A05B-B12C8DCD5CBDQ51439212-6CCD89F3-706C-47D4-9472-F15D6AA609F6Q52660791-3BDE7F52-6812-463F-8D5B-C181BCD9AF2DQ52714897-E1BCB7B5-3496-4283-BB2F-5B0B3CCA76C5Q80087597-D048ED5D-2433-4533-9095-8D5D3182BFDFQ90390840-214F88FA-5134-48F3-A8EC-EB2AF001873EQ92152395-68231239-0C60-476E-90C1-F2BA28CF3A39Q92739620-96C40A41-D727-4E9F-A92D-D04459F1C12EQ92757405-8DCF2B70-3BDE-44AC-AC04-27F8E8502436Q92965830-9D317D1E-DD08-485A-8F97-463CD332E80BQ93006316-4D00C840-9824-41A7-8560-3A109E3A1790Q93070355-18005594-9B0E-4988-9C5E-ACD169A23A48Q95260999-DB0786B3-CC23-485A-9BEF-B81E0FFF3EF5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lao H Saal
@ast
Lao H Saal
@en
Lao H Saal
@es
Lao H Saal
@nl
Lao H Saal
@sl
type
label
Lao H Saal
@ast
Lao H Saal
@en
Lao H Saal
@es
Lao H Saal
@nl
Lao H Saal
@sl
prefLabel
Lao H Saal
@ast
Lao H Saal
@en
Lao H Saal
@es
Lao H Saal
@nl
Lao H Saal
@sl
P1053
A-2919-2011
P106
P108
P31
P3829
P496
0000-0002-0815-1896
P569
2000-01-01T00:00:00Z